Changes in the level of endogenous adrenal steroids, testosterone, thyroid hormones, and prolactin in adult men diagnosed with chronic kidney diseases

Zoran Gluvić ,
Zoran Gluvić
Contact Zoran Gluvić

Zemun Clinical Hospital, Department of Endocrinology, Diabetes and mICU, School of Medicine, University of Belgrade , Belgrade , Serbia

Samardzic Vladimir ,
Samardzic Vladimir

Zemun Clinical Hospital, Department of Endocrinology, Diabetes and mICU, School of Medicine, University of Belgrade , Belgrade , Serbia

Lackovic Milena ,
Lackovic Milena

Zemun Clinical Hospital, Department of Endocrinology, Diabetes and mICU, School of Medicine, University of Belgrade , Belgrade , Serbia

Mladenovic Violeta ,
Mladenovic Violeta

Kragujevac Clinical Hospital, Clinic of Endocrinology and Diabetes, Faculty of medicine, University of Kragujevac , Kragujevac , Serbia

Radenkovic Sasa ,
Radenkovic Sasa

Niš Clinical Hospital, Clinic of Endocrinology and Diabetes, Faculty of medicine, University of Nis , Niš , Serbia

Obradovic Milan ,
Obradovic Milan

Department of Radiobiology and Molecular Genetics, VINČA Institute of Nuclear Sciences - National Institute of the Republic of Serbia, University of Belgrade , Belgrade , Serbia

Isenovic R. Esma
Isenovic R. Esma

Department of Radiobiology and Molecular Genetics, VINČA Institute of Nuclear Sciences - National Institute of the Republic of Serbia, University of Belgrade , Belgrade , Serbia

Published: 01.01.2020.

Volume 36, Issue 1 (2020)

pp. 1841-1848;

Abstract

We are the witnesses of a significant increase in chronic kidney diseases (CKD) occurrence. There is scarce literature evidence about functional integrity and natural adaptation of endocrine system axes in patients with different stages of always progressive CKD. Such a problem is growing with the beginning of renal replacement treatments (peritoneal and hemodialysis) or even with renal transplantation. The close monitoring of CKD patients by nephrologist and endocrinologist is mandatory because the natural adaptation of the endocrine system in CKD patients must be differed out of endocrine dysfunction, which has to be treated. Endocrine dysfunction management principles are mostly the same as for the patients with no CKD, except for close drug dose monitoring, especially in the circumstances with concomitant renal replacement treatment.

Keywords

References

1.
Xu LG, Xu HM, Zhu XF, Jin LM, Xu B, Wu Y, et al. Examination of the semen quality of patients with uraemia and renal transplant recipients in comparison with a control group. Andrologia. 41(4):235–40.
2.
Ross DS, Burch HB, Cooper DS, Greenlee MC, Laurberg P, Maia AL, et al. American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis. Thyroid. 2016;26(10):1343-1421.
3.
N’Gankam V, Uehlinger D, Dick B, Frey BM, Frey FJ. Increased cortisol metabolites and reduced activity of 11β-hydroxysteroid dehydrogenase in patients on hemodialysis. Kidney International. 61(5):1859–66.
4.
Arregger AL, Cardoso EM, Tumilasci O, Contreras LN. Diagnostic value of salivary cortisol in end stage renal disease. Steroids. 73(1):77–82.
5.
H R, H T. Circadian rhythm of salivary cortisol, plasma cortisol, and plasma ACTH in end-stage renal disease. Endocr Connect. 2(1):23–31.

Citation

Copyright

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. 

Article metrics

Google scholar: See link

The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Most read articles

Partners